Rocuronium Bromide Injection — FDA Drug Shortage
The FDA lists a drug shortage record for Rocuronium Bromide Injection (injection) from Hospira, Inc., a Pfizer Company with status Current. The shortage was first posted on 02/15/2023.
Shortage Details
- Status
- Current
- Company
- Hospira, Inc., a Pfizer Company
- Package NDC
- 0409-7037-10
- Dosage Form
- Injection
- Presentation
- Rocuronium Bromide, Injection, 100 mg/10 mL (10 mg/mL) (NDC 0409-7037-10)
- Initial Posting
- 02/15/2023
- Revised Date